Cambridge Research Biochemicals (CRB), offering expertise in the custom supply of research reagents, principally peptides and antibodies, has once again demonstrated customer satisfaction with the extension of an important contract in the medical research field.
Posts By: CRB
Target specific antibodies from Cambridge Research Biochemicals
The answer is “a cyclic peptide”, now what was the question? An interview with Dr. Ed Tate, Imperial College London
I spoke to Ed Tate recently. Ed was the 2013 winner of the Medimmune Protein & Peptide Science Award and was Plenary speaker at the RSC Protein & Peptide Science Group Early Stage Researcher meeting held in Durham in November 2013 which was sponsored by Cambridge Research Biochemicals. The Tate group is based in the Department of Chemistry at Imperial College London and their research… Read more »
Spectrum Peptides from CRB
Custom Antibody Generation to Deubiquitinating Enzyme – OTULIN
Custom Antibody Generation to Deubiquitinating Enzyme – OTULIN Ubiquitination of proteins: Ubiquitination is an important post translational modification (the addition to a protein after it has been synthesized) where ubiquitin is attached to a substrate protein. The addition of ubiquitin to a protein regulates many diverse processes: • Signaling for protein degradation through proteasomes/ lysosomes •… Read more »
CRB’s Expansion and Relocation
Company’s competition win leads to larger premises and new jobs.
Self-Assembling Cages from Coiled-Coil Peptide Modules
This paper in Science caught my eye earlier in the year. It is another peptide biomaterials paper for which I make no apology – this seems to be a really exciting area of peptide science right now. This is a publication from the laboratory of Prof. Dek Woolfson, University of Bristol, whose work is largely based around α-helical… Read more »
Peptide Biomaterials – the future of peptide science?
Back in the day, peptides were of interest because many hormones were peptides and analogues could be useful for treatment of endocrine disorders and various hormone-dependent cancers. Some, such as Zoladex (Goserelin acetate) even made it into the clinic. Then neuropeptides were (and still are) ‘the next big thing’. Of course, in all of these… Read more »
4th RSC Protein and Peptide Early Researcher Meeting – Collingwood College, University of Durham 11th November 2013
For the first time, the PPSG Early Stage Researcher Meeting (4th year) was held at the University Durham (Collingwood College) rather than London, making it easier for PhD and Post-Doctoral students from the North of England and Scotland to attend and present their research. Professor Alethea Tabor (University College London) was organising the Cambridge Research Biochemicals (CRB) sponsored event with… Read more »